MaxLinear Inc. Shares Surge Past Analyst Target: What’s Next for Investors?

In recent trading, MaxLinear Inc (Symbol: MXL) shares have exceeded the average analyst 12-month target price of $20.00, currently trading at $20.54 per share. When a stock surpasses its target price, analysts typically have two options: downgrade it due to valuation concerns, or raise their target to reflect the company’s positive performance. Their responses often hinge on the underlying business factors that have propelled the stock’s price upward.

Nine different analyst targets from the Zacks coverage universe help shape the average for MaxLinear Inc, but it’s important to note that this is simply a mathematical average. Some analysts maintain lower targets, with one predicting a price of $12.00, while another is quite optimistic with a target of $28.00. The standard deviation among these estimates is $6.00.

The reason to focus on the average price target is to benefit from a “wisdom of crowds” approach. This method consolidates the insights of various analysts rather than relying on a single expert’s opinion. Now that MXL has surpassed the average target price, investors have an opportunity to reevaluate the company. They must decide if $20.00 is merely a stepping stone towards an even higher target or if the current valuation warrants taking some profits. Below is the latest breakdown of analyst ratings for MaxLinear Inc:

The average rating in the table ranges from 1 to 5, where 1 represents a Strong Buy and 5 indicates a Strong Sell. This article features data from Zacks Investment Research via Quandl.com, where you can find the latest Zacks research report on MXL — at no cost.

10 ETFs With Most Upside To Analyst Targets »

Also see:

• Funds Holding HSEB
• GMF shares outstanding history
• PWR DMA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.